A carregar...
Estrogen Inhibition Reverses Pulmonary Arterial Hypertension and Associated Metabolic Defects
Increased estrogen is a strong epidemiologic risk factor for development of pulmonary arterial hypertension (PAH) in patients, associated with metabolic defects. Estrogens also drive penetrance in mice carrying mutations in BMPR2, the cause of most heritable PAH. The goal of the present study was to...
Na minha lista:
| Publicado no: | Eur Respir J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6532788/ https://ncbi.nlm.nih.gov/pubmed/28775043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02337-2016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|